Lupin launched raltegravir 600 mg tablets in the US as sole first-to-file applicant, eligible for 180 days of generic exclusivity.
Company news · Finvezto · 3 Nov 2026 · Lupin (LUPIN)
What happened
Lupin launched raltegravir 600 mg tablets in the US as sole first-to-file applicant, eligible for 180 days of generic exclusivity. Source: Stock note
Why it matters
Anand Ganapathy K: The product is a generic of Merck's Isentress HD and has annual US sales of $26 million, per IQVIA data for September 2026. Source: Stock note
Links
Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630.